In addition to the impact of the axis, leptin level alone displayed the positive correlation with poor outcome in ovarian cancer [13], and higher leptin level was found in multiple myeloma patients and associated with clinical stage [14]. This evidence concerns the gene LEP and ovarian carcinoma.